Cough clinical trials at UCSF
1 research study open to eligible people
Cough is a common symptom that everyone experiences. UCSF is recruiting participants for a study called ORV-PF-01 to learn about the effects of orvepitant on cough in patients with idiopathic pulmonary fibrosis. It is a two way, placebo controlled, cross-over study using two different doses of orvepitant. If you’re interested, contact UCSF to see if you qualify.
open to eligible people ages 40 years and up
ORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate the effect of two doses of orvepitant on cough in patients with IPF.
San Francisco, California and other locations